-
1
-
-
0035500487
-
Cellular senescence as a tumour-suppressor mechanism
-
Campisi, J. Cellular senescence as a tumour-suppressor mechanism. Trends Cell Biol. 11, S27-S31 (2001).
-
(2001)
Trends Cell Biol.
, vol.11
-
-
Campisi, J.1
-
2
-
-
0038013875
-
Senescence, apoptosis and therapy-cutting the lifelines of cancer
-
Schmitt, C. A. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nature Rev. Cancer 3, 286-295 (2003).
-
(2003)
Nature Rev. Cancer
, vol.3
, pp. 286-295
-
-
Schmitt, C.A.1
-
3
-
-
0030944985
-
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
-
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. &Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
-
(1997)
Cell
, vol.88
, pp. 593-602
-
-
Serrano, M.1
Lin, A.W.2
McCurrach, M.E.3
Beach, D.4
Lowe, S.W.5
-
5
-
-
0037667702
-
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
-
Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003).
-
(2003)
Cell
, vol.113
, pp. 703-716
-
-
Narita, M.1
-
6
-
-
0034632829
-
Regulation of chromatin structure by site-specific histone H3 methyltransferases
-
Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599 (2000).
-
(2000)
Nature
, vol.406
, pp. 593-599
-
-
Rea, S.1
-
7
-
-
0035797384
-
Rb targets histone H3 methylation and HP1 to promoters
-
Nielsen, S. J. et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-565 (2001).
-
(2001)
Nature
, vol.412
, pp. 561-565
-
-
Nielsen, S.J.1
-
8
-
-
0035282458
-
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
-
Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120-124 (2001).
-
(2001)
Nature
, vol.410
, pp. 120-124
-
-
Bannister, A.J.1
-
9
-
-
0035282573
-
Methylation of histone H3 lysine 9 creates a binding site for HPI proteins
-
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. &Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HPI proteins. Nature 410, 116-120 (2001).
-
(2001)
Nature
, vol.410
, pp. 116-120
-
-
Lachner, M.1
O'Carroll, D.2
Rea, S.3
Mechtler, K.4
Jenuwein, T.5
-
10
-
-
10744230436
-
A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells
-
Ait-Si-Ali, S. et al. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 23, 605-615 (2004).
-
(2004)
EMBO J.
, vol.23
, pp. 605-615
-
-
Ait-Si-Ali, S.1
-
11
-
-
0026555721
-
Retroviral infection accelerates T lymphomagenesis in e mu-N-ras transgenic mice by activating c-myc or N-myc
-
Haupt, Y., Harris, A. W. &Adams, J. M. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc. Oncogene 7, 981-986 (1992).
-
(1992)
Oncogene
, vol.7
, pp. 981-986
-
-
Haupt, Y.1
Harris, A.W.2
Adams, J.M.3
-
12
-
-
17944380227
-
Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability
-
Peters, A. H. et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-337 (2001).
-
(2001)
Cell
, vol.107
, pp. 323-337
-
-
Peters, A.H.1
-
13
-
-
0027203921
-
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
-
Kemp, C. J., Donehower, L. A., Bradley, A. &Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822 (1993).
-
(1993)
Cell
, vol.74
, pp. 813-822
-
-
Kemp, C.J.1
Donehower, L.A.2
Bradley, A.3
Balmain, A.4
-
14
-
-
0032190629
-
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signalling
-
Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signalling. Genes Dev. 12, 3008-3019 (1998).
-
(1998)
Genes Dev.
, vol.12
, pp. 3008-3019
-
-
Lin, A.W.1
-
15
-
-
7144223296
-
Gene action in the X-chromosome of the mouse (Mus musculus L.)
-
Lyon, M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190, 372-373 (1961).
-
(1961)
Nature
, vol.190
, pp. 372-373
-
-
Lyon, M.F.1
-
16
-
-
0035931859
-
1NK4a expression during cellular senescence
-
1NK4a expression during cellular senescence. Nature 409, 1067-1070 (2001).
-
(2001)
Nature
, vol.409
, pp. 1067-1070
-
-
Ohtani, N.1
-
17
-
-
17444388849
-
A senescence-like phenotype distinguishes tumour cells that undergo terminal proliferation arrest after exposure to anticancer agents
-
Chang, B. D. et al. A senescence-like phenotype distinguishes tumour cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59, 3761-3767 (1999).
-
(1999)
Cancer Res.
, vol.59
, pp. 3761-3767
-
-
Chang, B.D.1
-
18
-
-
0037013154
-
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
-
Schmitt, C. A. et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335-346 (2002).
-
(2002)
Cell
, vol.109
, pp. 335-346
-
-
Schmitt, C.A.1
-
19
-
-
0029047362
-
A biomarker that identifies senescent human cells in culture and in aging skin in vivo
-
Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
-
(1995)
Proc. Natl Acad. Sci. USA
, vol.92
, pp. 9363-9367
-
-
Dimri, G.P.1
-
20
-
-
0037112369
-
Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′- deoxycytidine
-
Nguyen, C. T. et al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62, 6456-6461 (2002).
-
(2002)
Cancer Res.
, vol.62
, pp. 6456-6461
-
-
Nguyen, C.T.1
-
21
-
-
0038412822
-
The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase
-
Fuks, F., Hurd, P. J., Deplus, R. &Kouzarides, T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31, 2305-2312 (2003).
-
(2003)
Nucleic Acids Res
, vol.31
, pp. 2305-2312
-
-
Fuks, F.1
Hurd, P.J.2
Deplus, R.3
Kouzarides, T.4
-
22
-
-
0142216208
-
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS
-
Leone, G., Voso, M. T., Teofili, L. &Lubbert, M. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. Clin. Immunol. 109, 89-102 (2003).
-
(2003)
Clin. Immunol.
, vol.109
, pp. 89-102
-
-
Leone, G.1
Voso, M.T.2
Teofili, L.3
Lubbert, M.4
-
23
-
-
0036134935
-
Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence
-
Rane, S. G., Cosenza, S. C., Mettus, R. V. &Reddy, E. P. Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol. Cell. Biol. 22, 644-656 (2002).
-
(2002)
Mol. Cell. Biol.
, vol.22
, pp. 644-656
-
-
Rane, S.G.1
Cosenza, S.C.2
Mettus, R.V.3
Reddy, E.P.4
-
24
-
-
0041883654
-
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
-
Guerra, C. et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4, 111-120 (2003).
-
(2003)
Cancer Cell
, vol.4
, pp. 111-120
-
-
Guerra, C.1
-
25
-
-
11144356354
-
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects
-
Tuveson, D. A. et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387 (2004).
-
(2004)
Cancer Cell
, vol.5
, pp. 375-387
-
-
Tuveson, D.A.1
-
26
-
-
0345275880
-
Inactivation of a histone methyltransferase by mutations in human cancers
-
Kim, K. C., Geng, L. &Huang, S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res. 63, 7619-7623 (2003).
-
(2003)
Cancer Res.
, vol.63
, pp. 7619-7623
-
-
Kim, K.C.1
Geng, L.2
Huang, S.3
-
27
-
-
0035449997
-
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
-
Steele-Perkins, G. et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15, 2250-2262 (2001).
-
(2001)
Genes Dev.
, vol.15
, pp. 2250-2262
-
-
Steele-Perkins, G.1
-
28
-
-
0033569423
-
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
-
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R. & Lowe, S. W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670-2677 (1999).
-
(1999)
Genes Dev.
, vol.13
, pp. 2670-2677
-
-
Schmitt, C.A.1
McCurrach, M.E.2
De Stanchina, E.3
Wallace-Brodeur, R.R.4
Lowe, S.W.5
-
29
-
-
0036527761
-
Dissecting p53 tumour suppressor functions in vivo
-
Schmitt, C. A. et al. Dissecting p53 tumour suppressor functions in vivo. Cancer Cell 1,289-298 (2002).
-
(2002)
Cancer Cell
, vol.1
, pp. 289-298
-
-
Schmitt, C.A.1
-
30
-
-
9444260942
-
Tumor cells escape suicide gene therapy by genetic and epigenetic instability
-
Frank, O. et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood 104, 3543-3549 (2004).
-
(2004)
Blood
, vol.104
, pp. 3543-3549
-
-
Frank, O.1
-
31
-
-
0037416206
-
T cell receptor gene rearrangement lineage analysis reveals clues for the origin of highly restricted antigen-specific repertoires
-
Hamrouni, A., Aublin, A., Guillaume, P. &Maryanski, J. L. T cell receptor gene rearrangement lineage analysis reveals clues for the origin of highly restricted antigen-specific repertoires. J. Exp. Med. 197, 601-614 (2003).
-
(2003)
J. Exp. Med.
, vol.197
, pp. 601-614
-
-
Hamrouni, A.1
Aublin, A.2
Guillaume, P.3
Maryanski, J.L.4
|